Zealand Pharma A/S (ZEAL:DC) (ZEAL) PT Lowered to DKK225 at Goldman Sachs, Following Clinical Business Update
Tweet Send to a Friend
Goldman Sachs analyst Graig Suvannavejh lowered the price target on ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
